High-Dose Naxitamab (Humanized-3F8) PLUS Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma: Outpatient Treament Low Immunogenicity, and Major Responses in a Phase II Trial

Kushner B.; Modak S.; Basu E.; Roberts S.; Mauguen A.; Pandit-Taskar N.; Cheung N. K.

首页> 外文期刊>Pediatric blood & cancer >High-Dose Naxitamab (Humanized-3F8) PLUS Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma: Outpatient Treament Low Immunogenicity, and Major Responses in a Phase II Trial

【24h】

High-Dose Naxitamab (Humanized-3F8) PLUS Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma: Outpatient Treament Low Immunogenicity, and Major Responses in a Phase II Trial

机译：高剂量纳克拉塔氨酰胺（人源化-3F8）加上粒细胞 - 巨噬细胞殖民地刺激因子的升级剂量：门诊术后低免疫原性，以及在II期试验中的主要反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共2页
作者
Kushner B.; Modak S.; Basu E.; Roberts S.; Mauguen A.; Pandit-Taskar N.; Cheung N. K.;
展开▼
作者单位

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr Pediat 1275 York Ave New York NY 10021 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献

1. High-Dose Naxitamab (Humanized-3F8) PLUS Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma: Outpatient Treament Low Immunogenicity, and Major Responses in a Phase II Trial [J] . Kushner B., Modak S., Basu E., Pediatric blood & cancer . 2019,第S4期

机译：高剂量纳克拉塔氨酰胺（人源化-3F8）加上粒细胞 - 巨噬细胞殖民地刺激因子的升级剂量：门诊术后低免疫原性，以及在II期试验中的主要反应
2. High-Dose Naxitamab (Humanized-3F8) Plus Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Relapsed Neuroblastoma Resistant to Salvage Therapy: A Phase II Trial [J] . Kushner B., Modak S., Basu E., Pediatric blood & cancer . 2019,第S4期

机译：高剂量纳克拉塔胺（人源化-3F8）加上粒细胞 - 巨噬细胞菌落刺激因子的升级剂量，用于复发的神经母细胞瘤，抗性治疗抗性瘤：II期试验
3. High-Dose Naxitamab (Humanized-3F8) Plus Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Consolidating >= 2nd Complete Remission of High-Risk Neuroblastoma [J] . Kushner B., Modak S., Basu E., Pediatric blood & cancer . 2019,第S4期

机译：高剂量纳克拉塔氨酰亚波（人源化-3F8）加上粒细胞 - 巨噬细胞菌落刺激因子的升级剂量> =第2天完全缓解高危神经母细胞瘤
4. Development of Friction Factor Correlation for Single-phase Flow in Micro-fin Tube Using Logistic Dose Response Curve Fitting Method [C] . Hou Kuan Tam, Lap Mou Tam, Afshin J. Ghajar, Advances in heat transfer and energy conservation . 2012

机译：Logistic剂量响应曲线拟合法开发微翅片管单相流摩擦因子相关性
5. Randomized Placebo-Controlled Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697) [O] . David H. Lawson, Sandra Lee, Fengmin Zhao, -1

机译：在完全手术切除局部无疾病证据的患者中酵母衍生的粒细胞-巨噬细胞集落刺激因子（GM-CSF）对肽疫苗对GM-CSF加肽疫苗对安慰剂的随机安慰剂对照III期试验晚期和/或IV期黑色素瘤：东部合作肿瘤小组的一项试验-美国放射线影像学学院癌症研究小组（E4697）
6. MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial [O] . Behrens, Frank, Tak, Paul P., Østergaard, Mikkel, 2015

机译：MOR103，一种针对粒细胞巨噬细胞集落刺激因子的人单克隆抗体，在中度类风湿关节炎患者的治疗中：Ib / IIa期随机，双盲，安慰剂对照，剂量递增试验的结果
7. Phase II Trial on the Effect of Low-Dose versus High-Dose Vitamin D Supplementation on Bone Mass in Adults with Neurofibromatosis 1 (NF1). [R] . Viskochil, D. 2017

机译：关于低剂量与高剂量维生素D补充对神经纤维瘤病1（NF1）成人骨量的影响的II期试验。

High-Dose Naxitamab (Humanized-3F8) PLUS Stepped-up Dosing of Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma: Outpatient Treament Low Immunogenicity, and Major Responses in a Phase II Trial

著录项

相似文献

相关主题

期刊订阅